4//SEC Filing
HAMPTON GEORGE P 4
Accession 0001209191-18-022376
CIK 0001492426other
Filed
Apr 1, 8:00 PM ET
Accepted
Apr 2, 4:24 PM ET
Size
9.0 KB
Accession
0001209191-18-022376
Insider Transaction Report
Form 4
HAMPTON GEORGE P
See remarks
Transactions
- Tax Payment
Ordinary Shares
2018-04-01$14.20/sh−2,755$39,121→ 41,473 total - Exercise/Conversion
Restricted Stock Units
2018-04-01−7,000→ 7,000 total→ Ordinary Shares (7,000 underlying) - Exercise/Conversion
Ordinary Shares
2018-04-01+7,000→ 44,228 total
Footnotes (3)
- [F1]Each restricted stock unit represents a contingent right to receive one ordinary share of the Issuer.
- [F2]Includes 477 ordinary shares of the Issuer acquired by the reporting person on December 1, 2017 pursuant to an employee stock purchase program.
- [F3]On April 1, 2015 and May 1, 2015, the reporting person was granted an aggregate of 28,000 restricted stock units. The restricted stock units vest in four equal annual installments beginning on April 1, 2016.
Documents
Issuer
Horizon Pharma plc
CIK 0001492426
Entity typeother
Related Parties
1- filerCIK 0001650147
Filing Metadata
- Form type
- 4
- Filed
- Apr 1, 8:00 PM ET
- Accepted
- Apr 2, 4:24 PM ET
- Size
- 9.0 KB